Tirzepatide

Browse clinics and online programs referencing tirzepatide for supervised weight management. Compare prescribers, pricing, and clinical oversight standards. This page is informational and does not diagnose, prescribe, or recommend therapies.

Looking for clinics by city? Explore peptide clinics in Miami , Los Angeles, and New York to compare verified providers by treatment focus.

Recovery peptide users often compare BPC-157 and TB-500, while metabolic health users usually cross-reference semaglutide.

If you are actively evaluating treatment access, you can compare semaglutide providers, get matched with a provider, or find a peptide clinic near you.

Common contexts

  • Commonly associated with advanced weight management and metabolic health clinic pathways.
  • Clinics may position tirzepatide as part of a broader obesity, insulin resistance, or longevity-oriented programme.
  • Listings often overlap with providers offering structured GLP-1 follow-up and behaviour change support.

Safety information

  • Tirzepatide is a prescription treatment and requires proper medical assessment before use.
  • Ask clinics to explain how they assess suitability, manage gastrointestinal side effects, and review progress over time.
  • Availability and prescribing practice can change, so verify current access and supervision directly.

Quick summary

  • Tirzepatide is a prescription dual-incretin medicine often researched through high-intent weight-management and metabolic clinics.
  • Users usually compare tirzepatide with semaglutide when they want to understand differences in programme intensity, cost, and tolerability.
  • Clinics vary widely in how they structure tirzepatide access, monitoring, and follow-up.
  • The best comparison points are clinician oversight, dose-escalation support, side-effect management, and total cost of care.
  • Tirzepatide often appears in premium or more intensive metabolic-health programmes, but that does not automatically make a clinic stronger.
  • This page is for research and provider comparison only, not treatment advice.

Evidence at a glance

A scannable summary of what the current research and UK/US regulatory position actually show. Educational only — not medical advice, and no dosing guidance.

Evidence
Very strong Phase 3 evidence: SURMOUNT-1 reported up to ~20.9% average weight loss at 72 weeks on the highest dose (vs ~3.1% placebo), and the SURMOUNT-5 head-to-head trial reported greater average weight loss with tirzepatide than semaglutide. An obstructive sleep apnoea indication was added in the US in December 2024.
Human data
Extensive — large Phase 3 programmes across diabetes and weight management, a direct head-to-head trial against semaglutide, and growing real-world prescribing data.
UK regulatory status
Licensed, prescription-only medicine in the UK: authorised for type 2 diabetes in 2022 and for weight management in November 2023, with NICE-recommended NHS access via specialist weight-management services alongside private prescribing.
US regulatory status
FDA-approved under separate products for type 2 diabetes, chronic weight management, and obstructive sleep apnoea in adults with obesity. Compounded copies are heavily restricted since the FDA declared the shortage resolved in October 2024.
Anti-doping (sport)
Dual-incretin medicines are not currently named on the WADA prohibited list; tested athletes should verify against the current list as it changes annually.

Last reviewed 14 August 2026. Regulatory status can change — always confirm the current position with a qualified clinician.

Claim vs evidence

Common marketing and internet claims about Tirzepatide, set against what the research actually shows. Educational only — not medical advice.

ClaimHuman evidenceWhat the evidence shows
Everyone loses 20%+ on tirzepatideTrial average, not guaranteeThe ~20.9% figure is the average on the highest dose in a supervised 72-week trial. Individual results vary widely with dose, tolerability, adherence, and baseline — averages describe populations, not promises.
Compounded or 'research' tirzepatide is a legal cheap routeRestrictedRoutine compounded copies ended when the FDA declared the shortage resolved in October 2024; only narrow exceptions remain. 'Research use' vials sold online are unregulated products with unverifiable contents — not the medicine the trials studied.
Tirzepatide is simply better than semaglutide for everyoneHead-to-head favours it on averageSURMOUNT-5 did report greater average weight loss with tirzepatide, but suitability is individual: tolerability, medical history, licensing, cost, and access differ. Which medicine — if either — fits a given person is a prescriber's judgement.

Clear intro

Tirzepatide pages usually sit slightly later in the buying journey, when patients are weighing programme strength, pricing, and tolerability against semaglutide. Clinics should be able to explain why tirzepatide fits a patient rather than assuming it is automatically the stronger option.

Who this is for

This page is most useful for patients comparing more intensive GLP-1-related pathways, structured metabolic support, and providers with stronger follow-up models.

What to ask before choosing a clinic

  • Why are you considering tirzepatide instead of semaglutide?
  • What escalation and side-effect support are included?
  • How often will progress and tolerability be reviewed?

Pricing and red flags

Tirzepatide programmes are often positioned above entry-level GLP-1 offers on price, especially when physician review and bundled support are more robust.

  • Clinics implying it is right for everyone.
  • No detail on review cadence or side-effect management.
  • Pricing that does not clarify what monitoring is included.

What is Tirzepatide?

Tirzepatide is a prescription treatment used in weight-management and metabolic-health settings. In practical directory terms, it usually appears on pages for clinics that want to position themselves as more advanced or more intensive in their GLP-1-related care. Patients most often encounter it when comparing alternatives to semaglutide.

How it works

At a high level, tirzepatide acts on more than one hormonal pathway involved in appetite and glucose regulation. Clinics often frame this as a more intensive metabolic option, but what matters most in real-world comparison is how they manage dosing, how they monitor tolerability, and whether the programme includes meaningful follow-up.

Typical use cases

  • Structured weight-management pathways for users comparing stronger or newer metabolic options.
  • Clinics that position themselves around obesity medicine, metabolic optimization, or concierge weight-loss support.
  • Patients already comparing semaglutide who want to understand whether a different prescribing pathway may be discussed.

Cost overview

Tirzepatide programmes are often priced at the upper end of GLP-1 clinic offers, though the number alone can be misleading. The main variables are prescriber access, follow-up cadence, and whether care includes diagnostics or lifestyle support. Use the peptide therapy cost guide to compare price bands in a more consistent way. See the peptide therapy cost guide.

What to expect from clinics

  • A credible clinic should explain why tirzepatide is being considered rather than assuming it is always preferable.
  • The intake should cover medical history, contraindications, goals, and how the clinic will handle progression or discontinuation.
  • Programmes often look premium on the page, so it is important to compare what is really included in the monthly fee.

Frequently asked questions about Tirzepatide

Is tirzepatide licensed in the UK?

Yes. Tirzepatide is a licensed, prescription-only medicine in the UK. The MHRA authorised it for type 2 diabetes in 2022 and, in November 2023, for weight management in adults with obesity, or with overweight alongside a weight-related health condition. NICE recommends it for weight management through specialist NHS weight-management services, subject to eligibility and local commissioning, so NHS and private routes differ and eligibility is assessed by a clinician.

Is tirzepatide approved in the US?

Yes. In the US, tirzepatide is FDA-approved under separate products for type 2 diabetes and for chronic weight management. As with semaglutide, approval attaches to a specific product and its licensed indication rather than to the substance in general.

Is compounded tirzepatide legal?

Much less so than it once was. The FDA declared the tirzepatide shortage resolved in October 2024, which ended the route by which pharmacies routinely compounded copies of the licensed products. Patient-specific 503A compounding where a documented clinical need exists, and narrow 503B outsourcing-facility supply, are the remaining exceptions — and in April 2026 the FDA proposed removing tirzepatide from the 503B bulk drug substances list, which would restrict large-scale compounding further still. Ask any provider offering a compounded version to set out the legal basis and the compounding pharmacy's credentials.

How does tirzepatide differ from semaglutide?

They are different molecules acting on different hormonal pathways — semaglutide acts on one incretin pathway, while tirzepatide acts on two. Clinics often present tirzepatide as the more intensive option, but newer or more intensive is not automatically more appropriate. Suitability depends on medical history, tolerability and what is licensed for a person's circumstances, and that is a prescriber's judgement rather than something to infer from a directory listing.

Can I buy tirzepatide without a prescription?

No. Tirzepatide is prescription-only in both the UK and the US. UK enforcement action has uncovered illicit manufacture of unlicensed weight-loss pens, including tirzepatide, and counterfeit products have been found to contain unpredictable quantities of active ingredient. Buying outside a regulated prescribing route carries genuine safety risk, and a legitimate clinic will always assess a patient before prescribing.

What should I ask a clinic offering tirzepatide?

Ask why tirzepatide is being suggested rather than an alternative; who prescribes and who reviews progress; how contraindications and current medications are checked; how side effects and treatment review are managed; and exactly what the monthly cost covers. Treat any clinic implying it is right for everyone with caution. This directory is informational and does not diagnose, prescribe, or recommend treatments.

Related comparisons: Retatrutide vs Tirzepatide, Survodutide vs Tirzepatide, Semaglutide vs Tirzepatide, Tirzepatide vs Sermorelin.

Next step

Compare Providers and Next Steps

If you are considering this treatment, compare providers, review your options, and choose the path that best fits your goals and preferred level of care.

Related Tirzepatide pages

Move from peptide research into clinic comparisons, guides, and matching.

Not sure whether local clinics or online options are the better fit? compare providers or use our matching tool to find the right next step. You can also learn how tirzepatide works before shortlisting clinics. If you want a broader market view first, find a peptide clinic near you.

Clinics offering Tirzepatide

LiveNow Longevity logo
RecommendedVerified

LiveNow Longevity

Las Vegas, NV, USA

LiveNow Longevity is a physician-led longevity and peptide clinic in Las Vegas — built on a simple promise: transparent medicine with no markup on your meds. Founded by board-certified neurologist Dr. Charles Kamen, MD, every patient starts with an $88 medical evaluation including baseline labs. From there, care can include peptide therapy, anti-aging treatments, GLP-1 weight loss (semaglutide and tirzepatide), NAD+ therapy, hormone optimization, and recovery support. In person in Las Vegas, or via telehealth across Nevada.

  • Doctor-led
Physician-led by Dr. Charles Kamen, MD
View Profile
Menon Health logo
FeaturedVerified

Menon Health

London, United Kingdom

Menon Health is a Mayfair-based peptide therapy clinic founded by Dr Mukil Menon, a GMC-registered physician and one of the first doctors to prescribe medical peptide therapy in the UK. Before establishing Menon Health, Dr Menon served as UK medical director at Koniver Wellness, launching the clinic at Soho House London. He continues to practise within the NHS alongside his private consultations, ensuring his protocols stay grounded in current medical standards. The clinic offers doctor-led, prescription-based peptide therapy alongside regenerative cell complex treatments, bloods and diagnostics, and IV therapy. All formulations are sourced from GMP-certified, EMA-regulated pharmacies and dispensed as pre-filled pens, vials, or multi-peptide syringes — Menon Health's approach to combining multiple peptides in a single dose is designed to improve precision and patient adherence. Based at 64 North Row in Mayfair, London, Menon Health serves patients across the UK, Europe, Canada, and the United States, with consultations available in person or remotely.

  • Google 3.7 (3)
GMC-registered physicians

From £195

View Profile
Medical Express Clinic logo

Medical Express Clinic

London, United Kingdom

Based in London, UK, Medical Express Clinic is a medical weight loss clinic. Its listed focus spans weight management. It holds a 4.2-star Google rating from 237 reviews.

  • Google 4.2 (237)
View Profile
The Virtual Slimming Clinic logo

The Virtual Slimming Clinic

London, United Kingdom

The Virtual Slimming Clinic is a medical weight loss clinic in London, UK. The clinic is associated with weight management. It holds a 3.9-star Google rating from 9 reviews.

  • Google 3.9 (9)
View Profile

Explore clinics by city

What to do next

Move from treatment research into provider comparison by choosing the next step that fits your buying journey. Some users want to compare programmes first, while others want a faster route into matched options or local clinic discovery.

If you want more context before comparing clinics, read the learn how tirzepatide works.

Next step

Explore suitable clinics

Move from peptide research into real provider comparison by checking city pages, cost context, and related treatment comparisons. Clinics vary more by oversight and programme structure than by peptide name alone.

Map preview
Mapbox map preview

For clinics

Are you a clinic?

Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.